The microbiology of chlamydia species have similarities to the microbiology of chronic diseases. Chlamydia species and other immortal pathogens have been identified in virtually every chronic disease; but were identified as “associations” rather than causes. Big pharma develops expensive new drugs, that treat symptoms and the biochemical aspects of part(s) of chronic diseases. The world cannot afford expensive drugs that only treat symptoms and the biochemical aspects of parts of a chronic disease, and does not treat the root causes or resolve the disease.